Rima Mounla, MD | |
10208 W 147th St, Overland Park, KS 66221-9659 | |
(502) 963-1031 | |
Not Available |
Full Name | Rima Mounla |
---|---|
Gender | Female |
Speciality | Pediatrics - Neonatal-perinatal Medicine |
Location | 10208 W 147th St, Overland Park, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093264723 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 34017 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rima Mounla, MD 10208 W 147th St, Overland Park, KS 66221-9659 Ph: () - | Rima Mounla, MD 10208 W 147th St, Overland Park, KS 66221-9659 Ph: (502) 963-1031 |
News Archive
OncoGenex Pharmaceuticals, Inc. today announced final results from a Phase 1 trial. The primary purpose of this trial was to evaluate the safety and tolerability of OGX-427 up to doses of 1000 mg for the treatment of various solid tumors. Patients enrolled had a diagnosis of castrate resistant prostate cancer, breast cancer, ovarian cancer or non-small cell lung cancer.
University of Colorado researchers have found lower vaccination rates among children who receive liver transplants, increasing the risk of sickness for those children, who already face significant health issues.
UnitedHealth Group (NYSE: UNH) announced today that the company will cover the administration of the H1N1 (swine flu) vaccine for its members whose health benefit plans cover immunizations, and also cover the administration of the vaccine for members whose plans currently do not include immunizations and do not plan to in the future.
A report to be published in an upcoming issue of the World Health Organisation (WHO) Bulletin will call for urgent attention to the politically sensitive issue of border control, and the need for coherent and robust national plans in the face of a catastrophic flu pandemic.
With the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across most of the world, scientists are working strenuously to find effective therapies or vaccines. Most strategies being worked on at present are targeting viral entry into the host cells, mainly through the interaction of the SARS-CoV-2 S protein with the angiotensin-converting enzyme 2 (ACE2) receptor.
› Verified 3 days ago
Dr. Fred Fletcher Roberts, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5610 W 131st Ter, Overland Park, KS 66209 Phone: 913-402-9813 | |
Patricia C Bell, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5808 W 110th St, Overland Park, KS 66211 Phone: 913-696-8000 Fax: 816-302-9939 | |
Jennifer P Bernard, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 12541 Foster St, Suite 300, Overland Park, KS 66213 Phone: 913-317-3200 Fax: 913-317-3218 | |
Dr. Robert Vincent Jackson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8901 W 74th St, Suite 10, Overland Park, KS 66204 Phone: 913-362-1660 | |
Dr. Kathryn Ann Hartman, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8901 W 74th St, Overland Park, KS 66204 Phone: 913-362-1660 | |
Brynn E Everist, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 8675 College Blvd Ste 200, Overland Park, KS 66210 Phone: 913-491-5501 |